FDA NDC Directory · JSON-LD · Markdown

nintedanib

NDC 68462-802 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerGlenmark Pharmaceuticals Inc., USA
Marketing categoryAbbreviated NDA (generic) · App ANDA212555
Dosage form / routeCAPSULE · ORAL
Active ingredientsNINTEDANIB ESYLATE (100 mg/1)
Marketing started20260709
Package count1

External sources

Source: openFDA. Public-domain (CC0).